Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.01
(
1.02%
)
US TECH 100
26,736.40
(
1.03%
)
Dow Jones
49,652.14
(
1.62%
)
Brent Oil
111.62
(
1.15%
)
Bitcoin
76,606.98
(
0.36%
)
News Focus
News Focus
Post# of 704048
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

lostalot

Send PM Follow Ignore
Followers 3
Posts 921
Boards Moderated 0
Alias Born 07/08/2002

lostalot

Re: MyHunch post# 430705

Sunday, 10/16/2005 11:10:51 AM

Sunday, October 16, 2005 11:10:51 AM

Post# of 704048
MyHunch: In the article that you posted "In September, the U.S. government gave Sanofi Aventis' (NYSE:SNY - News) vaccine unit a $97 million, five-year contract to produce a mammalian, cell-based flu vaccine."

CRXL is the one that licenses its cell-based technology to Sanofi Aventis for flu vac production. I believe CRXL will have a great potential even though it has tremendous run this yr.


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today